日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

头颈部复发性鳞状细胞癌患者挽救性切除术后辅助使用纳武利尤单抗的II期临床试验

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-4554
Leddon, Jennifer L; Gulati, Shuchi; Haque, Sulsal; Allen, Casey; Palackdharry, Sarah; Mathews, Maria; Kurtzweil, Nicky; Riaz, Muhammed Kashif; Takiar, Vinita; Nagasaka, Misako; Patil, Yash; Zender, Chad; Tang, Alice; Cervenka, Brian; McGrath, Julie; Korn, W Michael; Hinrichs, Benjamin H; Jandarov, Roman; Harun, Nusrat; Sukari, Ammar; Wise-Draper, Trisha M
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Going back to class I: MHC and immunotherapies for childhood cancer

回到第一课：MHC 和儿童癌症的免疫疗法

期刊:Pediatric Blood & Cancer
影响因子:2.3
doi:10.1002/pbc.25359
Haworth, Kellie B; Leddon, Jennifer L; Chen, Chun-Yu; Horwitz, Edwin M; Mackall, Crystal L; Cripe, Timothy P
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2015
文献求助 收藏

VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells.

VEGF阻断可部分通过调节肿瘤内髓系细胞来实现溶瘤病毒疗法

期刊:Molecular Therapy
影响因子:12
doi:10.1038/mt.2013.39
Currier Mark A, Eshun Francis K, Sholl Allyson, Chernoguz Artur, Crawford Kelly, Divanovic Senad, Boon Louis, Goins William F, Frischer Jason S, Collins Margaret H, Leddon Jennifer L, Baird William H, Haseley Amy, Streby Keri A, Wang Pin-Yi, Hendrickson Brett W, Brekken Rolf A, Kaur Balveen, Hildeman David, Cripe Timothy P
肿瘤
VEGF
发表日期：2013
文献求助 收藏